Akston Biosciences
Chemicals & Related Products · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 Cummings Ctr Ste 454C, Beverly, Mass...Phone Number
(978) 969-3381Website
www.akstonbio.comRevenue
$16.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co.), Akston has partnered with Dechra Pharmaceuticals PLC to commercialize once-a-week canine and feline insulin therapies. It operates a GMP biologics manufacturing facility and research laboratory at its Beverly, Mass. location. www.akstonbio.com.Explore more
Akston Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Akston Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Akston Biosciences is spiking on competitors!
Akston Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Akston Biosciences has new funding data
Check if Akston Biosciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Akston Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Akston Biosciences
Click to see if Akston Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when Akston Biosciences launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Akston Biosciences
Compare insights from companies similar to Akston Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
Akston Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Akston Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Akston Biosciences.
Akston Biosciences financials insights
Gather financial insights about Akston Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Akston Biosciences Tech Stack
A closer look at the technologies used by Akston Biosciences
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Spending/Investment, Manufacturing Operations
Open Position
Partnership
Partnership, Research & Development, Medical Research, Pharmaceuticals
Executive Move
Board of Directors
Funding
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Akston Biosciences
Sign Up For FreeTo access detailed company insights
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co.), Akston h... Read More
